Total: £ 56.28
2026-05-15 | Pages: 94 | Tables: 91
The global TQB2450 market was valued at US$ 83.00 million in 2025 and is anticipated to reach US$ 319 million by 2032, at a CAGR of 13.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
2026-05-15 | Pages: 95 | Tables: 91
The global Mirogabalin Besilate Tablets market was valued at US$ 490 million in 2025 and is anticipated to reach US$ 1184 million by 2032, at a CAGR of 12.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glob...
2026-05-15 | Pages: 95 | Tables: 103
The global Shengagliptin Phosphate Tablets market was valued at US$ 12.50 million in 2025 and is anticipated to reach US$ 58.30 million by 2032, at a CAGR of 12.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-05-15 | Pages: 92 | Tables: 102
The global Benzoic Acid Retagliptin Tablets market was valued at US$ 59.70 million in 2025 and is anticipated to reach US$ 31.85 million by 2032, at a CAGR of 6.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-05-15 | Pages: 117 | Tables: 109
The global Zinc Acetate Tablets market was valued at US$ 182 million in 2025 and is anticipated to reach US$ 263 million by 2032, at a CAGR of 5.4% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-05-15 | Pages: 101 | Tables: 103
The global Tralametinib market was valued at US$ 7.50 million in 2025 and is anticipated to reach US$ 75.69 million by 2032, at a CAGR of 22.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-05-15 | Pages: 97 | Tables: 90
The global Anainterleukin market was valued at US$ 5460 million in 2025 and is anticipated to reach US$ 15490 million by 2032, at a CAGR of 16.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic ...
2026-05-15 | Pages: 100 | Tables: 105
The global Talazoparib Tosylate market was valued at US$ 2260 million in 2025 and is anticipated to reach US$ 4509 million by 2032, at a CAGR of 10.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econ...
2026-05-15 | Pages: 102 | Tables: 94
The global Iptacopan Hydrochloride Capsules market was valued at US$ 188 million in 2025 and is anticipated to reach US$ 950 million by 2032, at a CAGR of 11.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-05-15 | Pages: 97 | Tables: 102
The global Talacotuzumab market was valued at US$ 73.00 million in 2025 and is anticipated to reach US$ 115 million by 2032, at a CAGR of 4.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-05-15 | Pages: 94 | Tables: 103
The global Ibrexafungerp Citrate Tablets market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 988 million by 2032, at a CAGR of 11.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glob...
2026-05-15 | Pages: 114 | Tables: 108
The global Budesonide and Formoterol Fumarate market was valued at US$ 2500 million in 2025 and is anticipated to reach US$ 4007 million by 2032, at a CAGR of 6.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-05-15 | Pages: 92 | Tables: 96
The global Pegturocoagulin alfa market was valued at US$ 1050 million in 2025 and is anticipated to reach US$ 3527 million by 2032, at a CAGR of 18.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econ...
2026-05-15 | Pages: 93 | Tables: 91
The global Zolbetuximab market was valued at US$ 420 million in 2025 and is anticipated to reach US$ 2539 million by 2032, at a CAGR of 17.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-05-15 | Pages: 102 | Tables: 90
The global Tuvonralimab market was valued at US$ 80.00 million in 2025 and is anticipated to reach US$ 455 million by 2032, at a CAGR of 10.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...